44.41USD0.00%Mkt Cap: 2.02B USDP/E: 100.95Last update: 2026-05-26
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in …
Industry Peers
Health Information Services25.85BUSDP/E 29.1
11.66BUSDP/E 78.1
8.39BUSD—
7.49BSEKP/E 33.5
7.35BUSDP/E 35.7
5.05BTRYP/E 27.0
4.13BUSD—
3.79BUSDP/E 29.5
Indicators:|
Key Statistics
Company
Market Cap2.02B USD
Enterprise Value1.95B USD
Revenue (TTM)1.23B USD
Gross Profit503.44M USD
Net Income (TTM)2.05M USD
Revenue/Share26.84 USD
Last Price44.41 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.5K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISINUS68213N1090
Valuation
P/E (Trailing)100.95
P/E (Forward)19.94
PEG15.40
EV/EBITDA26.53
EV/Revenue1.59
P/S1.62
P/B1.60
EPS (TTM)0.44
EPS (Forward)2.19
52W Range
26.8562% of range55.00
52W High55.00 USD
52W Low26.85 USD
Profitability
Gross Margin42.49%
Oper. Margin5.44%
EBITDA Margin6.01%
Profit Margin0.17%
ROE0.17%
ROA0.10%
Growth
Revenue Growth14.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF127.30M USD
CapEx (TTM)57.93M USD
FCF Margin9.19%
FCF Yield5.57%
Net Debt-37.04M USD
Net Debt/EBITDA-0.50
Balance Sheet
Debt/Equity0.17
Current Ratio1.50
Quick Ratio1.04
Book Value/Sh27.36 USD
Cash/Share5.260 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)61.29 USD
Target Range55.00 USD – 70.00 USD
# Analysts7
Ownership
Shares Out.45.48M
Float41.97M
Insiders2.14%
Institutions105.72%
Short Interest
Short Ratio4.6d
Short % Float7.20%
Short % Out.5.93%
Shares Short2.70M
Short (prev mo.)2.50M
Technical
SMA 5038.19 (+16.3%)
SMA 20037.85 (+17.3%)
Beta0.96
S&P 52W Chg28.31%
Avg Vol (30d)592.53K
Avg Vol (10d)501.46K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—